The goal of the Cancer Therapy Evaluation Program (CTEP) is to facilitate the process of bringing promising, novel, investigational anticancer and anti-HIV agents to the public as quickly and as safely as possible. CTEP offers a unique combination of resources and expertise to assist an Industry Collaborator in clinical development of new therapeutic agents and the ability to evaluate investigational agents in a wide variety of tumor types and disease settings. This section of the CTEP web site provides information regarding the process for co-developing an investigational anticancer agent with the NCI. In addition, we have provided links to other online resources to assist with technology development, clinical development resources, and small business research funding.
For those of you who want to learn about the policies and procedures involved in clinical drug development, CTEP has developed the Investigator's Handbook (now available online!). If you want to find information on research and funding by NCI for AIDS-related malignancies, we have developed the Office of HIV AIDS Malignancy (OHAM) site for basic and clinical research. We hope you find this information useful, and please give us feedback on how we can make this site more useful.